Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

04. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2981


	Articles 1 - 20 / 59609

	Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer. Crit Rev Oncol Hematol Girolimetti G, Bramato G, Fiore A, Romano R, Guerra F, Bucci C, Basset A. PMID: 41933855 [PubMed - as supplied by publisher]
	Demographic and Prognostic Significance of Surgically-Treated Intrathyroidal Thymic Carcinoma: A Systematic Review and Meta-Analysis. World J Surg Jenkins CR, Hajibandeh S, Hajibandeh S, Scott-Coombes DM, Egan RJ. PMID: 41931541 [PubMed - as supplied by publisher]
	Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis. Eur J Cancer Filis P, Markozannes G, Salgkamis D, Tsiknakis N, Zerdes I, Pagkalidou E, Manou M, Filis N, Papakonstantinou A, Mavroudis D, Matikas A, Tsilidis KK, Foukakis T. PMID: 41930854 [PubMed - as supplied by publisher]
	Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives. Oncol Res Wang S, Wang M, Yao W. PMID: 41930147 [PubMed - indexed for MEDLINE]
	Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review. Cureus Hussain F, Huba M, Paracha A, Kwait B, Siddiqui Z, Patel H, Lee A, Patel H, Palati S, Papale A, Copeland-Halperin RS, King D. PMID: 41930062 [PubMed]
	Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic. Front Immunol Yan J, Ou H, Wang S, Jin K, Yu X, Wu W. PMID: 41929491 [PubMed - indexed for MEDLINE]
	Automated Extraction of Cancer Registry Data from Pathology Reports: Comparing LLM-Based and Ontology-Driven NLP Platforms. medRxiv McPhaul T, Kreimeyer K, Baras A, Botsis T. PMID: 41929331 [PubMed]
	Osteopontin in pancreatic cancer: A systematic review. Med Int (Lond) Weber GF. PMID: 41928921 [PubMed]
	Systematic review and meta-analysis comparing postoperative and oncological outcomes between local excision plus radiotherapy versus total mesorectal excision for rectal cancer. World J Surg Oncol Kitaguchi D, Forgione A, Innocenzi C, Yang Y, Espínola F, Giménez M, Oda T, Marescaux J. PMID: 41928271 [PubMed - as supplied by publisher]
	Interpretation of constitutional cancer predisposition gene variants in 14â€ˆ765 individuals in the 100â€ˆ000 Genomes Project cancer arm: a retrospective cohort analysis. Lancet Oncol Whitworth J, Wang VY, Black D, Davies HR, Degasperi A, Prepelita D, Nik-Zainal S. PMID: 41926963 [PubMed - indexed for MEDLINE]
	[(177)Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study. Lancet Oncol Sandhu S, Joshua AM, Emmett L, Bressel M, Anton A, Spain L, Horvath LG, Pasam A, Tolmeijer SH, Akhurst TJ, Alipour R, Banks P, Buteau JP, Cassidy E, Crumbaker M, Dhiantravan N, Xu W, Chan J, Hitchen N, Scalzo M, Ravi Kumar AS, Kong G, Wallace R, Williams N, Williams S, Haynes NM, Neeson P, Wyatt AW, Hicks RJ, Hofman MS. PMID: 41926961 [PubMed - indexed for MEDLINE]
	Oxaliplatin-induced peripheral neuropathy in cancer treatment: Mechanisms, risk factors, and management strategies. Adv Clin Exp Med Pigo, Banach M, Walkowiak PS, Zygulska A. PMID: 41926777 [PubMed - as supplied by publisher]
	Reply to: "Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology," "Key Methodological Considerations in the Interpretation of the CONKO-007 Trial," and "Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer". J Clin Oncol Fietkau R, Semrau S, Kallies A, Adler W, Oettle H. PMID: 41926724 [PubMed - as supplied by publisher]
	Efficacy and safety of radical antegrade modular pancreatosplenectomy versus standard radical pancreatosplenectomy for pancreatic body/tail cancer: A systematic review and meta-analysis. Surgery Zhou D, Han Y, Xia N, Huang X, Wang Z, Cai S, Tian B, Xiong J. PMID: 41924794 [PubMed - as supplied by publisher]
	Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. Drug Des Devel Ther Eslinger C, Sonbol MB, George B, Babiker H, Borad MJ, Bekaii-Saab TS. PMID: 41924551 [PubMed - indexed for MEDLINE]
	Circulating fatty acids and risk of gastrointestinal cancer in the UK Biobank. Front Nutr Liu Y, Zhu Z, Yang C. PMID: 41923914 [PubMed]
	A real-world study on the prognosis of patients with pancreatic cancer: A prospective stationary survey from 2007-2020. Intern Med Abe A, Ohyama H, Asahina Y, Nagasaka K, Tohyama S, Amano H, Takaoka S, Imai Y, Hirose S, Asakawa Y, Yokouchi R, Sato N, Hasegawa Y, Takano A, Iimuro Y, Kojima Y, Mochizuki H, Kato J, Omata M. PMID: 41922232 [PubMed - as supplied by publisher]
	Mimicking Metastatic Renal Cell Carcinoma: A Case of Pancreatic Tail Neuroendocrine Neoplasm on 68Ga-LNC1007 PET/CT. Clin Nucl Med Zang J, Peng Y, Liu Q, Hu S, Miao W. PMID: 41921938 [PubMed - indexed for MEDLINE]
	PCO26-278: Genetically Determined Circulating Metabolites and Pancreatic Cancer Risk: Causal Insights From a Systematic Review of Mendelian Randomization Studies. J Natl Compr Canc Netw Bodrova E, Pasnoor DS, Dash S, Gupta M, Patel K, Ahmed MN, Reddy SA, Asfeen U, Jain A, Desai R. PMID: 41921564 [PubMed - in process]
	EPR26-148: Mismatch Between Clinical Severity and Palliative Care in Lower-Income ZIPs: A National Study of Pancreatic Cancer Hospitalizations. J Natl Compr Canc Netw Uddin MA, Khan F. PMID: 41921555 [PubMed - in process]

Articles 1 - 20 / 59609

Page 1 de 2981



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité